ADVERTISEMENT

Torrent Pharma Q1 Results Review- Segment Continues To Drive Growth: Centrum

The brokerage sees majority of the positives being already factored in the current price, hence downgrade to Add.

<div class="paragraphs"><p>Various medicines arranged for photograph. (Source: freepik)</p></div>
Various medicines arranged for photograph. (Source: freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy. 
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit